Identification of Novel Nuclear RGS10 Binding Partners
新型核 RGS10 结合伴侣的鉴定
基本信息
- 批准号:9296748
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2019-01-31
- 项目状态:已结题
- 来源:
- 关键词:Amino Acid SequenceAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesBindingBinding ProteinsBiochemicalBiological ModelsBrainCell NucleusCell membraneCell physiologyCellsChromatinCo-ImmunoprecipitationsCytokine GeneDNADNA BindingDNA SequenceDNA-Binding ProteinsDataDiseaseG-Protein-Coupled ReceptorsG-substrateGTP-Binding Protein RegulatorsGTP-Binding Protein alpha SubunitsGTP-Binding ProteinsGene TargetingGenesGenetic TranscriptionImmuneInflammationInflammatoryKnowledgeMediatingMicrogliaMultiple SclerosisMultiprotein ComplexesNF-kappa BNeuraxisNeurodegenerative DisordersNuclearNuclear ProteinNuclear ProteinsNuclear TranslocationOutcomeParkinson DiseasePathogenesisPhysiologicalPlayPoint MutationProductionPromoter RegionsProteinsProteomicsRGS DomainRGS ProteinsRegulationReportingRestRoleSeriesSignal PathwaySignal TransductionSignaling ProteinSiteSpecificityTNF geneTestingTimeTranscriptional ActivationTranscriptional RegulationWorkcell typechromatin immunoprecipitationchromatin proteincytokineexperimental studyfactor Agene interactioninsightknock-downliquid chromatography mass spectrometrymacrophagenervous system disorderneuroinflammationnew therapeutic targetnext generation sequencingnovelnovel therapeutic interventionpromotertranscription factor
项目摘要
Regulator of G-protein Signaling 10 (RGS10) regulates inflammatory signaling pathways in microglia and is
implicated in multiple inflammatory disease states. However, the mechanism by which RGS10 controls
microglial cell physiology and pathogenesis are undefined. The known biochemical function of RGS10 is to
regulate G-protein signaling downstream of G-protein coupled receptors, but this mechanism does not account
for RGS10's effects in microglia. RGS10 is enriched in the nucleus of microglia, and it regulates transcription of
pro-inflammatory cytokines. Preliminary data suggest that RGS10 functions to regulate transcription by a
novel, unknown nuclear mechanism involving indirect chromatin interaction. This represents an unexpected
new paradigm in RGS-domain function. However, the specificity of RGS10-DNA interactions and identity of
nuclear proteins that mediate the interaction with DNA are unknown. We hypothesize that RGS10 regulates
proinflammatory cytokine production by interactions with transcription factors or transcription factor binding
proteins in promoter regions of proinflammatory cytokine genes. The objectives of this study are to test this
hypothesis, and to generate new testable hypotheses about the physiologic role of RGS10 by fully defining
RGS10 protein and DNA interactions in the nucleus of microglia. Specifically, nuclear RGS10 interactions with
protein and DNA will be analyzed using unbiased proteomics and next generation sequencing approaches in
microglia in the following aims: Aim 1. Define specific DNA sequences associated with nuclear RGS10 in
resting and activated microglia. Chromatin Immunoprecipitation followed by next generation sequencing will
be used to define specific target sequences associated with nuclear RGS10 and determine whether the profile
of target sites is altered following microglial activation. Sequences implicated by unbiased approaches will be
confirmed by direct ChIP-PCR. Aim 2. Define RGS10 interactions with nuclear proteins in resting and
activated microglia, and determine whether these interactions mediate RGS10 association with DNA.
RGS10 co-immunoprecipitation will be performed in nuclear protein extracts from resting and activated
microglia, and proteomics analysis of the enriched proteins using LC/MS will identify the nuclear RGS10
interactome. Protein sequences identified in the proteomics study will be confirmed by a series of direct
biochemical analyses. Finally, the role of specific RGS10 protein binding partners in mediating the RGS10-
DNA interactions defined in Aim 1 will be determined by performing ChIP-PCR following knock-down of
specific protein binding partners. The outcome of the proposed project will be to define the first nuclear
interactome for an RGS protein and identify for the first time specific sites of RGS protein-chromatin
interaction.
G蛋白信号调节因子10(RGS 10)调节小胶质细胞中的炎症信号通路,
与多种炎性疾病状态有关。然而,RGS 10控制的机制
小神经胶质细胞的生理学和发病机制尚未明确。RGS 10的已知生化功能是
调节G-蛋白偶联受体下游的G-蛋白信号传导,但这种机制并不能解释
RGS 10在小胶质细胞中的作用RGS 10在小胶质细胞的细胞核中富集,并且它调节
促炎细胞因子。初步数据表明,RGS 10的功能是通过调节转录。
涉及间接染色质相互作用的新的、未知的核机制。这代表了一个意想不到的
RGS域功能的新范例。然而,RGS 10-DNA相互作用的特异性和
介导与DNA相互作用的核蛋白是未知的。我们假设RGS 10调节
通过与转录因子相互作用或转录因子结合产生促炎细胞因子
促炎细胞因子基因启动子区的蛋白质。本研究的目的是验证这一点。
假设,并通过充分定义RGS 10的生理作用来产生新的可检验的假设
RGS 10蛋白和DNA在小胶质细胞核中的相互作用。具体而言,核RGS 10与
蛋白质和DNA将使用无偏蛋白质组学和下一代测序方法进行分析,
小胶质细胞在以下目标:目标1。定义与细胞核RGS 10相关的特定DNA序列,
休眠和激活的小胶质细胞。染色质免疫沉淀,然后进行下一代测序,
用于定义与核RGS 10相关的特异性靶序列,并确定该谱是否
在小胶质细胞激活后,靶位点的变化。无偏方法所涉及的序列将被
通过直接ChIP-PCR确认。目标二。定义RGS 10与静息和静息细胞核蛋白的相互作用,
激活的小胶质细胞,并确定这些相互作用是否介导RGS 10与DNA的关联。
RGS 10共免疫沉淀将在来自静息和活化细胞的核蛋白提取物中进行。
使用LC/MS对富集的蛋白质进行蛋白质组学分析将鉴定核RGS 10
相互作用体在蛋白质组学研究中鉴定的蛋白质序列将通过一系列直接测序来证实。
生化分析最后,研究了特异性RGS 10蛋白结合伴侣在介导RGS 10-
目标1中定义的DNA相互作用将通过在敲低以下基因后进行ChIP-PCR来确定:
特异性蛋白质结合伴侣。拟议项目的结果将是确定第一个核
RGS蛋白的相互作用基因组,并首次鉴定RGS蛋白-染色质的特异性位点
互动
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shelley B Hooks其他文献
Interleukin-1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel-associated acute pain syndrome.
在紫杉醇相关的急性疼痛综合征期间,小胶质细胞释放的白介素-1β启动脊髓背角谷氨酸能活性的增强。
- DOI:
10.1002/glia.23557 - 发表时间:
2019 - 期刊:
- 影响因子:6.2
- 作者:
Xisheng Yan;Fen Li;Dylan W Maixner;Ruchi Yadav;Mei Gao;Mourad Wagdy Ali;Shelley B Hooks;Han-Rong Weng - 通讯作者:
Han-Rong Weng
Shelley B Hooks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shelley B Hooks', 18)}}的其他基金
Assay development and screening for small molecule RGS10 regulators to target neuroinflammation
针对神经炎症的小分子 RGS10 调节剂的测定开发和筛选
- 批准号:
9977073 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
Assay development and screening for small molecule RGS10 regulators to target neuroinflammation
针对神经炎症的小分子 RGS10 调节剂的测定开发和筛选
- 批准号:
9808243 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
Modulation of RGS proteins and Ovarian Cancer Chemoresistance
RGS 蛋白的调节和卵巢癌化疗耐药
- 批准号:
8323000 - 财政年份:2010
- 资助金额:
$ 22.5万 - 项目类别:
Modulation of RGS proteins and Ovarian Cancer Chemoresistance
RGS 蛋白的调节和卵巢癌化疗耐药
- 批准号:
7939178 - 财政年份:2010
- 资助金额:
$ 22.5万 - 项目类别:
Regulation of dopamine signaling by striatal RGS9-2; mechanisms and specificity
纹状体 RGS9-2 调节多巴胺信号传导;
- 批准号:
7012487 - 财政年份:2006
- 资助金额:
$ 22.5万 - 项目类别:
GGL-RGS proteins: bifunctional G-protein regulators
GGL-RGS 蛋白:双功能 G 蛋白调节剂
- 批准号:
6552268 - 财政年份:2002
- 资助金额:
$ 22.5万 - 项目类别:
GGL-RGS proteins: bifunctional G-protein regulators
GGL-RGS 蛋白:双功能 G 蛋白调节剂
- 批准号:
6630419 - 财政年份:2002
- 资助金额:
$ 22.5万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 22.5万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 22.5万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 22.5万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 22.5万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 22.5万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 22.5万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 22.5万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 22.5万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 22.5万 - 项目类别: